Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Everolimus × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Specimen Handling 47 pembrolizumab 35 Magnetic Resonance Spectroscopy 33 Biopsy 33 Cisplatin 25 Carboplatin 21 Nivolumab 19 Cyclophosphamide 17 Radiotherapy 12 Radiation 12 Paclitaxel 12 X-Rays 11 Vincristine 11 Platinum 11 Gemcitabine 11 Doxorubicin 11 atezolizumab 10 Rituximab 10 Dexamethasone 10 1,2-diaminocyclohexaneplatinum II citrate 10 fludarabine 9 Prednisone 9 Etoposide 9 olaparib 8 ibrutinib 8 Taxes 8 Melphalan 8 Lenalidomide 8 Cytarabine 8 venetoclax 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03049189 2026-04-06

COMPETE

ITM Solucin GmbH

Phase 3 Active not recruiting

324 enrolled 15 charts

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡